PE-Cy7 Mouse Anti-Human CD123 Antibody (S-R442)

Name: PE-Cy7 Mouse Anti-Human CD123 Antibody (S-R442)S0B5515
Brand: Starter/斯達特
Price: 1000 CNY
Availability: InStock

產(chǎn)品型號：S0B5515

更新時間：2025-10-09

廠商性質(zhì)：生產(chǎn)廠家

訪問量：469

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

流式抗體封閉：如何有效避免實驗中的假陽性結(jié)果？

PKM1如何調(diào)控胚胎心肌細胞的能量代謝與增殖過程？

IHC抗體在癌癥生物標(biāo)志物檢測中如何實現(xiàn)精準(zhǔn)選擇？

IFN-γ抗體能否破解腫瘤微環(huán)境中的劑量悖論？

產(chǎn)品介紹

CD123, also known as the alpha chain of the interleukin-3 receptor （IL-3Rα）, is a membrane-bound protein that plays a crucial role in immune regulation and hematopoiesis. It is overexpressed in various hematologic malignancies, including acute myeloid leukemia （AML）, blastic plasmacytoid dendritic cell neoplasm （BPDCN）, acute lymphoblastic leukemia （ALL）, hairy cell leukemia, and systemic mastocytosis. The CD123 protein consists of three extracellular domains, a single-pass transmembrane domain, and a short intracellular region. It is involved in the growth, proliferation, survival, and differentiation of hematopoietic cells. CD123 is particularly significant as a biomarker for targeted therapy in these diseases, with various pharmacologic strategies and agents under investigation or already approved for clinical use. For instance, Tagraxofusp, an anti-CD123 antibody conjugated to diphtheria toxin, has been approved for use in patients with BPDCN.

上一個：S0B5516PE-Cy7 Mouse Anti-Human HLA-DR Antibody (S-R566)